REG - Burford Capital Ltd - Director/PDMR Shareholding

Burford CapitalAnnouncement

30/12/2022 13:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221230:nRSd3865La&default-theme=true

RNS Number : 3865L  Burford Capital Limited  30 December 2022

 

30 December 2022

 

 

BURFORD CAPITAL LIMITED

 

Notification of a transaction by a person discharging managerial
responsibilities

 

Burford Capital Limited, the leading global finance and asset management firm
focused on law, provides the following notification of a transaction by a
person discharging managerial responsibilities ("PDMR").

 

On September 30, 2022, Jordan Licht, Burford's Chief Financial Officer was
granted 103,212 shares under the Burford Capital 2016 Long Term Incentive
Plan.

 

The Notification of Dealing Form for this transaction is included at the end
of this announcement.

 

 

For further information, please contact:

 

 Burford Capital Limited
 For investor and analyst inquiries:
 Robert Bailhache, Head of Investor Relations, EMEA and Asia - email  +44 (0)20 3530 2023
 (mailto:rbailhache@burfordcapital.com)
 Jim Ballan, Head of Investor Relations, Americas - email             +1 (646) 793 9176
 (mailto:JBallan@burfordcapital.com)
 For press inquiries:
 David Helfenbein, Vice President, Public Relations - email           +1 (212) 235 6824
 (mailto:dhelfenbein@burfordcapital.com)

 Numis Securities Limited - NOMAD and Joint Broker                    +44 (0)20 7260 1000
 Giles Rolls
 Charlie Farquhar

 Jefferies International Limited - Joint Broker                       +44 (0)20 7029 8000
 Graham Davidson
 Tony White

 Berenberg - Joint Broker                                             +44 (0)20 3207 7800
 Toby Flaux
 Arnav Kapoor

About Burford Capital

Burford Capital is the leading global finance and asset management firm
focused on law. Its businesses include litigation finance
(https://www.burfordcapital.com/) and risk management, asset recovery and a
wide range of legal finance and advisory activities. Burford is publicly
traded on the New York Stock Exchange (NYSE: BUR) and the London Stock
Exchange (LSE: BUR), and it works with companies and law firms around the
world from its principal offices in New York, London, Chicago, Washington, DC,
Singapore, Sydney and Hong Kong.

 

For more information, please visit www.burfordcapital.com
(http://www.burfordcapital.com) .

 

 

This communication shall not constitute an offer to sell or the solicitation
of an offer to buy any ordinary shares or other securities of Burford.

 

This release does not constitute an offer of any Burford fund. Burford Capital
Investment Management LLC, which acts as the fund manager of all Burford
funds, is registered as an investment adviser with the US Securities and
Exchange Commission. The information provided herein is for informational
purposes only. Past performance is not indicative of future results. The
information contained herein is not, and should not be construed as, an offer
to sell or the solicitation of an offer to buy any securities (including,
without limitation, interests or shares in the funds). Any such offer or
solicitation may be made only by means of a final confidential private
placement memorandum and other offering documents.

 

Forward-looking statements

This announcement contains "forward-looking statements" within the meaning of
Section 21E of the US Securities Exchange Act of 1934, as amended, regarding
assumptions, expectations, projections, intentions and beliefs about future
events. These statements are intended as "forward-looking statements". In some
cases, predictive, future-tense or forward-looking words such as "aim",
"anticipate", "believe", "continue", "could", "estimate", "expect",
"forecast", "guidance", "intend", "may", "plan", "potential", "predict",
"projected", "should" or "will" or the negative of such terms or other
comparable terminology are intended to identify forward-looking statements,
but are not the exclusive means of identifying such statements. In addition,
we and our representatives may from time to time make other oral or written
statements which are forward-looking statements, including in our periodic
reports that we file with, or furnish to, the US Securities and Exchange
Commission (the "SEC"), other information sent to our security holders and
other written materials. By their nature, forward-looking statements involve
known and unknown risks, uncertainties and other factors because they relate
to events and depend on circumstances that may or may not occur in the future.
We caution you that forward-looking statements are not guarantees of future
performance and are based on numerous assumptions, expectations, projections,
intentions and beliefs and that our actual results of operations, including
our financial position and liquidity, and the development of the industry in
which we operate, may differ materially from (and be more negative than) those
made in, or suggested by, the forward-looking statements contained in this
announcement. Significant factors that may cause actual results to differ from
those we expect include those discussed under "Risk Factors" in our annual
report on Form 20-F filed with the SEC on March 29, 2022, our interim report
on Form 6-K furnished to the SEC on August 9, 2022, and other reports or
documents that we file with, or furnish to, the US Securities and Exchange
Commission from time to time. In addition, even if our results of operations,
including our financial position and liquidity, and the development of the
industry in which we operate are consistent with the forward-looking
statements contained in this announcement, those results of operations or
developments may not be indicative of results of operations or developments in
subsequent periods.

 

Except as required by law, we undertake no obligation to update or revise the
forward-looking statements contained in this announcement, whether as a result
of new information, future events or otherwise.

 

 1  Details of the person discharging managerial responsibilities/person closely
    associated
    (a)     Name                                                             Jordan Licht
 2  Reason for the notification
    (a)     Position/status                                                  A PDMR occupying the position of Chief Financial Officer
    (b)    Initial notification /Amendment                                   Initial
 3  Details of the issuer, emission allowance market participant, auction
    platform, auctioneer or auction monitor
    (a)     Name                                                             Burford Capital Limited
    (b)    LEI                                                               549300FUKUWFYJMT2277
 4  Details of the transaction(s): section to be repeated for (i) each type of
    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
    place where transactions have been conducted
    (a)     Description of the financial instrument, type of instrument      Ordinary shares of nil par value
             Identification code                                             GG00BMGYLN96
    (b)    Nature of the transaction                                         Grant of share award under the Burford Capital 2016 Long Term Incentive Plan
    (c)     Price(s)and volume(s)                                            Price(s)                                 Volume(s)
    $ 7.27                                                                                                            103,212

    (d)    Aggregated information                                            N/A

    ·    Aggregated volume

    ·    Price
    (e)    Date of the transaction                                           September 30, 2022

    (f)     Place of the transaction                                         N/A

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHXBLFXLLLFFBF